Crossref
Tafamidis may Stabilise Progression of Atrial Myopathy in Transthyretin Cardiac Amyloidosis
Heart, Lung and Circulation · 2026-08 · 35 · S183
DOI: 10.1016/j.hlc.2026.07.201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Heart, Lung and Circulation, 2026-08. Verfasst von A. Boyd und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Boyd, A., Geenty, P., Pham, J., Emerson, P., & Thomas, L. (2026). Tafamidis may Stabilise Progression of Atrial Myopathy in Transthyretin Cardiac Amyloidosis. Heart, Lung and Circulation, 35, S183. https://doi.org/10.1016/j.hlc.2026.07.201
Vancouver
Boyd A, Geenty P, Pham J, Emerson P, Thomas L. Tafamidis may Stabilise Progression of Atrial Myopathy in Transthyretin Cardiac Amyloidosis. Heart, Lung and Circulation. 2026;35:S183. doi:10.1016/j.hlc.2026.07.201
BibTeX
@article{Boyd2026,
author = {Boyd, A. and Geenty, P. and Pham, J. and Emerson, P. and Thomas, L.},
title = {Tafamidis may Stabilise Progression of Atrial Myopathy in Transthyretin Cardiac Amyloidosis},
journal = {Heart, Lung and Circulation},
year = {2026},
volume = {35},
pages = {S183},
doi = {10.1016/j.hlc.2026.07.201}
}
EUVIMED